... infarction Drug-eluting stent High bleeding risk Percutaneous coronary intervention The introduction of drug-eluting stents (DESs) revolutionized percutaneous coronary intervention (PCI) by significantly reducing rates of restenosis compared to bare-metal stents. The availability of DES allowed...

...Nazila Yaliqin; Salamaiti Aimaier; Dilare Adi; Yi-Tong Ma; Zi-Xiang Yu Background: Diabetes mellitus (DM) increases the risk of mortality in patients with acute myocardial infarction (AMI). The impact of the diabetes duration on the long-term outcome of those with percutaneous coronary intervention...

... underwent percutaneous coronary intervention with the Supra family of SES from two real-world Indian registries (891 patients from T-Flex registry and 933 patients from Tetriflex real-world registry). The primary endpoint was the incidence of target lesion failure (TLF) defined as a composite of cardiac...

... a topic of debate. We sought to study the safety and feasibility of combined BAV and percutaneous coronary intervention (BAV-PCI). Methods: Between November 2009 and July 2020, all patients undergoing BAV were identified and divided into three groups: combined BAV-PCI (group A), BAV with significant...

.... Methods: This was a retrospective, multicenter, observational study conducted between January 2015 and December 2019. The data on patients with ULMCA who underwent revascularization through percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) were stratified by the hemoglobin...

... percutaneous coronary intervention (PCI). Our meta-analysis aimed to demonstrate whether intensified antithrombotic regimens with ticagrelor plus aspirin have more beneficial effects and fewer adverse events compared to those of clopidogrel plus aspirin in East Asian patients with ACS undergoing PCI. Methods...

... of proximal coronary lesions, which are relatively more difficult to treat and were associated with worse clinical outcomes in the early percutaneous coronary intervention (PCI) era. Data regarding the outcomes of ostial lesions’ PCI in the contemporary era are lacking. Methods: We conducted a single-center...

...Erik Träff; Dimitrios Venetsanos; Karin Alpkvist; Sofia Sederholm Lawesson; Mikolaj Skibniewski; Sammy Zwackman; Joakim Alfredsson Introduction: Potential benefit with potent platelet inhibition in patients with chronic coronary syndrome (CCS) undergoing percutaneous coronary intervention (PCI) has...

... sacubitril/valsartan on N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) and left ventricular ejection fraction (LVEF) in patients with acute anterior STEMI undergoing percutaneous coronary intervention (PCI). Methods: We enrolled patients with acute anterior wall STEMI who underwent emergency PCI...

... fibrillation (AF) undergoing percutaneous coronary intervention (PCI) and suggest a short course of triple antithrombotic therapy (TAT) for those at very high thrombotic risk (TR) but low bleeding risk (BR). Methods: We analyze if the PARIS ischemic-hemorrhagic scale could be useful for the choice...

... to randomize lesions to percutaneous coronary intervention in native vessels and SVG. Aims: The aim of this study was to compare the rate of mortality, MI, and TLR across stent and vessel types. Methods: In this substudy, 6,087 patients with a single lesion in native vessels and 164 in SVG were followed for 5...

... is recommended only after coronary anatomy has been delineated and percutaneous coronary intervention (PCI) is planned, or before angiography in ST-elevation myocardial infarction (STEMI) patients who are treated with primary PCI. This is in keeping with the TRITON-TIMI 38 protocol and the results of the ACCOAST...

... Percutaneous coronary intervention Meta-analysis P2Y 12 inhibitors are effective antiplatelet agents which act by blocking P2Y 12 receptors on the platelet. P2Y 12 inhibitors in combination with aspirin are recommended as dual antiplatelet therapy regimens in European guidelines following...

...; Alastair N.J. Graham; David Hildick-Smith; Leif Thuesen; Evald Høj Christiansen; NOBLE Study Investigators Background: In the treatment of left main coronary artery (LMCA) disease, patients’ age may affect the clinical outcome after percutaneous coronary intervention (PCI) or coronary artery bypass...

...Ya-feng Zhang; Da-dong Liu; Yue Zhou; Ji-zhuang Lou Absrtact Background: Percutaneous coronary intervention (PCI) has been an effective treatment for acute coronary syndrome (ACS) patients. Acute kidney injury (AKI) is one of the common complications after PCI, which seriously affects the living...

...Pradyumna Agasthi; Chieh-Ju Chao; Panwen Wang; Eric H. Yang; Reza Arsanjani National Cardiovascular Data Registry (NCDR)-based logistic regression model is available for clinicians to predict in-hospital all-cause mortality after a percutaneous coronary intervention (PCI). However, this model has...

... is a valuable tool for treating complex and resistant coronary lesions. Its efficacy and safety are well established and when applied appropriately, it helps to achieve optimal outcomes for our patients. Laser Percutaneous coronary intervention Calcified coronary arteries Resistant coronary lesions...

... percutaneous coronary intervention (PCI) is controversial. Dual therapy (clopidogrel and a direct oral anticoagulant [DOAC]) is safer than triple therapy (warfarin, aspirin, and clopidogrel), while efficacy is unclear. We aimed to evaluate thrombin generation (TG) under dual and triple therapy. Methods...

... . 10.1016/j.jvs.2017.06.114 . 16. Kim   Y , Lee   JW , Lee   SY , Bae   JW , Lee   SJ , Jeong   MH , et al.   Feasibility of primary percutaneous coronary intervention via the distal radial approach in patients with ST-elevation myocardial infarction . Korean J Intern Med . 2020...

..., percutaneous coronary intervention, and coronary bypass grafting, nor in 1-year mortality or guideline-based therapy following ACS. Patients with schizophrenia had higher prevalence rates of diabetes, chronic obstructive pulmonary disease, and stroke, and a lower prevalence of hypertension ( p < 0.05...